ITRI vs RELY

ITRI exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a highly attractive valuation profile, trading significantly below its growth-based intrinsic value of $191.75. While the technical trend is bearish and insider sentiment is low, the company's profitability is robust with an ROE of 19.26% and a PEG ratio of 0.82, indicating the stock is undervalued relative to its earnings growth. The primary concern is a recent decline in revenue growth (-6.70%), though this is heavily offset by massive earnings growth (73.60%) and a consistent track record of earnings beats. Overall, the data suggests a value-driven entry point for a company with strong operational efficiency.

RELY exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a robust liquidity profile (Current Ratio 3.30). While the company is successfully transitioning to profitability with explosive YoY EPS growth and consistent earnings beats, it trades at a significant premium to its Graham Number ($5.36) and Intrinsic Value ($2.17). This valuation gap is partially mitigated by a low Forward P/E of 13.08, suggesting high expected earnings growth. However, aggressive insider selling totaling $195.56M creates a significant headwind that offsets the bullish analyst consensus.